Daratumumab Plus Bortezomib, Melphalan, and Prednisone (D-Vmp) Versus Bortezomib, Melphalan, and Prednisone (Vmp) Alone in Transplant-Ineligible Patients with Newly Diagnosed Multiple Myeloma (Ndmm): Updated Analysis of the Phase 3 Alcyone Study

AuthID
 P-00Y-1RF
25
Author(s)
Mateos, MV
·
Suzuki, K
·
Jakubowiak, A
·
Knop, S
·
Lucio, P
·
Nagy, Z
·
[+5]·
Shelekhova, T
·
Yoon, SS
·
Iosava, G
·
Fujisaki, T
·
Garg, M
·
Pei, HL
·
Krevvata, M
·
Carson, R
·
Borgsten, F
·
Dimopoulos, MA
View all authors
Document Type
Abstract
Year published
2022
Published
in BLOOD, ISSN: 0006-4971
Volume: 140, Pages: 10157-10159 (3)
Indexing
Wos®
Google Scholar®
Publication Identifiers
Wos: WOS:000893230303073
Source Identifiers
ISSN: 0006-4971
Export Publication Metadata
Marked List
 Add to Marked List
Info
At this moment we don't have any links to full text documens.
All authors
Name Order Name   Name Order Name   Name Order Name
1 Mateos, MV;   2 San-Miguel, J;   3 Cavo, M;
4 Creixenti, JB;   5 Suzuki, K;   6 Jakubowiak, A;
7 Knop, S;   8 Doyen, C;   9 Lucio, P;
10 Nagy, Z;   11 Pour, L;   12 Grosicki, S;
13 Crepaldi, AH;   14 Liberati, AM;   15 Campbell, P;
16 Shelekhova, T;   17 Yoon, SS;   18 Iosava, G;
19 Fujisaki, T;   20 Garg, M;   21 Pei, HL;
22 Krevvata, M;   23 Carson, R;   24 Borgsten, F;
25 Dimopoulos, MA;    

A place for researchers and their institutions

Useful Links

Get Help

© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service